These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11978158)

  • 1. Tolterodine-associated acute mixed liver injury.
    Schlienger RG; Keller MJ; Krähenbühl S
    Ann Pharmacother; 2002 May; 36(5):817-9. PubMed ID: 11978158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
    Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of mixed urinary incontinence].
    Goepel M
    Urologe A; 2003 Jun; 42(6):812-7. PubMed ID: 12851773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and tolerability of tolterodine for the treatment of overactive bladder in adults.
    Roberts RG; Garely AD; Bavendam T
    Am J Manag Care; 2005 Jul; 11(4 Suppl):S158-62. PubMed ID: 16161389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolterodine use for symptoms of overactive bladder.
    Ruscin JM; Morgenstern NE
    Ann Pharmacother; 1999 Oct; 33(10):1073-82. PubMed ID: 10534221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinations with tolterodine.
    Williams SG; Staudenmeier J
    Psychiatr Serv; 2004 Nov; 55(11):1318-9. PubMed ID: 15534031
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation. The International Study Group.
    Jonas U; Höfner K; Madersbacher H; Holmdahl TH
    World J Urol; 1997; 15(2):144-51. PubMed ID: 9144906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syndrome of inappropriate antidiuretic hormone associated with tolterodine therapy.
    Bryan MK; Nguyen MT; Hilas O
    Consult Pharm; 2010 May; 25(5):320-2. PubMed ID: 20497930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolterodine-warfarin drug interaction.
    Colucci VJ; Rivey MP
    Ann Pharmacother; 1999 Nov; 33(11):1173-6. PubMed ID: 10573314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolterodine: a clinical review.
    Crandall C
    J Womens Health Gend Based Med; 2001 Oct; 10(8):735-43. PubMed ID: 11703885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolterodine.
    Nurs Times; 2006 Jun 6-12; 102(23):27. PubMed ID: 16784047
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolterodine causes measurable restoration of urethral sensation in women with urge urinary incontinence.
    Kenton K; Lowenstein L; Brubaker L
    Neurourol Urodyn; 2010 Apr; 29(4):555-7. PubMed ID: 19771598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The overactive bladder in children: a potential future indication for tolterodine.
    Hjälmås K; Hellström AL; Mogren K; Läckgren G; Stenberg A
    BJU Int; 2001 Apr; 87(6):569-74. PubMed ID: 11298060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of tolterodine in nonneurogenic voiding dysfunction.
    Babu R
    Indian Pediatr; 2006 Nov; 43(11):980-3. PubMed ID: 17151401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence.
    Roehrborn CG; Abrams P; Rovner ES; Kaplan SA; Herschorn S; Guan Z
    BJU Int; 2006 May; 97(5):1003-6. PubMed ID: 16643482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors.
    Edwards KR; O'Connor JT
    J Am Geriatr Soc; 2002 Jun; 50(6):1165-6. PubMed ID: 12110086
    [No Abstract]   [Full Text] [Related]  

  • 17. Does gender or age affect the efficacy and safety of tolterodine?
    Michel MC; Schneider T; Krege S; Goepel M
    J Urol; 2002 Sep; 168(3):1027-31. PubMed ID: 12187215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study.
    Rentzhog L; Stanton SL; Cardozo L; Nelson E; Fall M; Abrams P
    Br J Urol; 1998 Jan; 81(1):42-8. PubMed ID: 9467475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder.
    Swift S; Garely A; Dimpfl T; Payne C;
    Int Urogynecol J Pelvic Floor Dysfunct; 2003 Feb; 14(1):50-4; discussion 54-5. PubMed ID: 12601517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials.
    Nijman RJ; Borgstein NG; Ellsworth P; Djurhuus JC
    J Urol; 2005 Apr; 173(4):1334-9. PubMed ID: 15758796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.